January 14, 2024 Responses of primary human nasal epithelial cellsto COVID-19 vaccine candidate Upper respiratory tract is the primary target of SARS-CoV-2. Therefore, nasal immune responses act as the first line of defense against SARS-CoV-2 infection. read more COVID-19 vaccine, delivery systems, primary human nasal epithelial cells, RBD, SARS-CoV-2
